{
  "zip": "77055",
  "sector": "Healthcare",
  "longBusinessSummary": "Burzynski Research Institute, Inc. operates a research and development facility of drugs for use in the treatment of cancer in the United States. The company focuses on the research, development, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also provides consulting services. Burzynski Research Institute, Inc. was founded in 1977 and is based in Houston, Texas.",
  "city": "Houston",
  "phone": "713 335 5697",
  "state": "TX",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.burzynskiclinic.com",
  "maxAge": 1,
  "address1": "9432 Katy Freeway",
  "industry": "Biotechnology",
  "address2": "Suite 200",
  "previousClose": 0.018,
  "regularMarketOpen": 0.025,
  "twoHundredDayAverage": 0.030503597,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.025,
  "navPrice": null,
  "averageDailyVolume10Day": 1425,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.018,
  "fiftyDayAverage": 0.022878787,
  "trailingAnnualDividendRate": null,
  "open": 0.025,
  "averageVolume10days": 1425,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 2.229516,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.025,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 5000,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 3286200,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 6107,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.025,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 5000,
  "fiftyTwoWeekHigh": 0.097,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.006,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.025,
  "exchange": "PNK",
  "shortName": "BURZYNSKI RESEARCH INSTITUTE IN",
  "longName": "Burzynski Research Institute, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "BZYR",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_3103438",
  "uuid": "0526e589-30c2-3c17-8803-e11702c7bdcb",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 131448000,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": -0.002,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1582934400,
  "heldPercentInstitutions": 0,
  "netIncomeToCommon": -1542458,
  "trailingEps": -0.012,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.81004995,
  "nextFiscalYearEnd": 1646092800,
  "mostRecentQuarter": 1598832000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 24968632,
  "enterpriseValue": 2364361,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.025,
  "logo_url": "https://logo.clearbit.com/burzynskiclinic.com"
}